Is Fischer Medical Ventures a Good Buy After Its Q1 FY27 Results?

The Fischer Medical Ventures share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Fischer Medical Ventures is formerly Fischer Chemic, a company that pivoted to manufacturing and distributing medical equipment including MRI systems and diagnostic devices, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.

Revenue for the quarter came in at Rs 83 crore, up 169.8% year on year, while profit after tax came in at Rs 3.79 crore, down 22.0% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Fischer Medical Ventures share price from here.

This piece works through the quarter's financial highlights, the business factors behind the numbers, where the Fischer Medical Ventures share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.

Click Here – Get Free Investment Predictions

Fischer Medical Ventures Q1 FY27 Financial Highlights

Metric	Q1 FY27	Q1 FY26	YoY Change
Revenue	Rs 83 crore	Rs 31 crore	169.8%
EBITDA	Rs 13 crore	Rs 12 crore	10.1%
Operating Margin	15.6%	48.9%	NA
Profit Before Tax	Rs 7.83 crore	Rs 10 crore	-21.9%
Net Profit / (Loss)	Rs 3.79 crore	Rs 4.86 crore	-22.0%

Fischer Medical Ventures Q1 FY27 Performance Analysis

Check Fischer Medical Ventures Fundamentals on Univest Screener

Revenue growth of 169.8% for the quarter came from steady demand across the company's core business, keeping the topline trend intact for the medical equipment manufacturing and healthcare technology sector.

Profitability is where the quarter disappointed. PAT fell 22% year on year to Rs 3.79 crore even as revenue grew, which points to margin or cost pressure that management will need to address. This gap between top-line and bottom-line performance is the key thing weighing on the Fischer Medical Ventures share price this quarter.

On a sequential basis, revenue moved down 15.2% sequentially from Rs 98 crore in the March 2026 quarter and net profit moved up 130.5% sequentially from -Rs 12 crore in the prior quarter, giving a fuller picture of the trend behind the Fischer Medical Ventures share price than the year on year comparison alone.

Key Business Factors in Q1 FY27

Revenue Trend

Fischer Medical Ventures' revenue grew 169.8% year on year this quarter, taking the quarterly base to Rs 83 crore in a medical equipment manufacturing and healthcare technology business that remains sensitive to demand and pricing cycles that ultimately feed through to the Fischer Medical Ventures share price.

Margin Movement

EBITDA rose 10.1% to Rs 13 crore, and operating margin moved to 15.6% from 48.9% a year earlier, a sign that cost control or pricing held up during the quarter.

Balance Sheet Position

Fischer Medical Ventures carries a low debt-to-equity ratio of 0.28, giving it a conservative balance sheet heading into the rest of FY27.

Valuation Context

The stock trades at a PE of 99.4x against an industry average of 58.6x, a premium that this quarter's results will need to justify going forward.

Dividend Details

No interim dividend was declared alongside Fischer Medical Ventures' Q1 FY27 results. The stock currently carries a trailing dividend yield of 0.13%, based on dividends paid over the last year. Investors tracking the Fischer Medical Ventures share price for income should watch the company's announcements around its next annual results for any dividend decision.

Fischer Medical Ventures Share Price Outlook for FY27

The key question for the rest of FY27 is whether Fischer Medical Ventures can arrest the margin pressure seen this quarter. Revenue growth alone will not be enough to support the Fischer Medical Ventures share price if profitability keeps slipping, so investors should watch the next couple of quarters for signs of a turnaround in the bottom line.

A stabilising or improving margin trend in the next result would be the clearest signal that this quarter's profit decline was a temporary setback rather than the start of a longer slide for the Fischer Medical Ventures share price.

Fischer Medical Ventures Stock Performance

Download the Univest iOS App or Univest Android App to track Fischer Medical Ventures' live share price and get daily stock updates.

The Fischer Medical Ventures share price was trading around Rs 35 as results season played out in late August 2026, roughly 72.0% below its 52-week high of Rs 125 and well above its 52-week low of Rs 31.

The Fischer Medical Ventures share price has likely already absorbed some of this quarter's disappointment, but further downside is possible if the next results confirm the same trend rather than a one-off. On profitability ratios, the company reports a return on equity of 8.06% and a book value of around Rs 7 per share, both useful reference points when judging whether the current price is reasonable.

Key Risks

Valuation Risk

At 99.4x earnings against an industry average of 58.6x, the stock leaves little room for disappointment if growth slows.

Profitability Risk

The quarter's profit trend is the clearest risk here. Until Fischer Medical Ventures shows a sustained improvement in margins or the bottom line, the stock is likely to stay volatile around results.

Sector and Demand Risk

As a medical equipment manufacturing and healthcare technology business, Fischer Medical Ventures' results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Fischer Medical Ventures share price well before the next result.

Conclusion

Fischer Medical Ventures' Q1 FY27 results show a business still growing its top line but losing ground on profitability, with PAT down 22% to Rs 3.79 crore even as revenue rose. The Fischer Medical Ventures share price reflects a stock in wait-and-watch mode, and it is not an obvious buy purely on this quarter's numbers until the margin trend turns around.

Frequently Asked Questions on Fischer Medical Ventures Q1 FY27 Results

What were Fischer Medical Ventures' Q1 FY27 results?

Ans. Fischer Medical Ventures reported Q1 FY27 revenue of Rs 83 crore, up 169.8% year on year, and PAT of Rs 3.79 crore, down 22.0% year on year.

Is Fischer Medical Ventures a good buy after its Q1 FY27 results?

Ans. Fischer Medical Ventures' profitability came under pressure this quarter, which makes this a stock to watch rather than an obvious buy purely on this result. Investors should form their own view based on their own risk appetite and time horizon.

What is the Fischer Medical Ventures share price today?

Ans. The Fischer Medical Ventures share price was trading around Rs 35 in late August 2026, about 72.0% below its 52-week high of Rs 125 and well above its 52-week low of Rs 31.

What is Fischer Medical Ventures' revenue and profit for Q1 FY27?

Ans. Fischer Medical Ventures reported revenue of Rs 83 crore and a net profit of Rs 3.79 crore for the quarter ended June 30, 2026.

Did Fischer Medical Ventures declare a dividend with its Q1 FY27 results?

Ans. No interim dividend was declared alongside Fischer Medical Ventures' Q1 FY27 results. Investors should track the company's next annual results for any dividend announcement.

What is Fischer Medical Ventures' PE ratio and is it expensive?

Ans. The Fischer Medical Ventures share price trades at a trailing PE of 99.4x, against an industry average of 58.6x. Investors should compare this with the company's growth rate before judging value.

What are the key risks for Fischer Medical Ventures investors right now?

Ans. At 99.4x earnings against an industry average of 58.6x, the stock leaves little room for disappointment if growth slows. As a medical equipment manufacturing and healthcare technology business, Fischer Medical Ventures' results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Fischer Medical Ventures share price well before the next result.

What is Fischer Medical Ventures' promoter shareholding?

Ans. Promoter shareholding data for Fischer Medical Ventures was not fully available for this quarter and should be checked on the company's official filings.